Zydus Lifesciences Limited (“Zydus”), a leading innovation-driven global lifesciences company, has received regulatory approval from the Drugs Controller General of India (DCGI) to commence two Phase...
Intra-Cellular Therapies, Inc. announced the presentation of a new network meta-analysis (NMA) demonstrating that CAPLYTA® (lumateperone) showed the greatest improvement across four key efficacy outcomes among...
Intervein Research Labs Pvt. Ltd. has successfully completed a recent inspection by the U.S. Food and Drug Administration, marking a key milestone in its regulatory...